Free Trial

Warby Parker (WRBY) Competitors

Warby Parker logo
$27.02 +0.95 (+3.64%)
Closing price 08/22/2025 03:59 PM Eastern
Extended Trading
$27.08 +0.06 (+0.21%)
As of 08/22/2025 05:52 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

WRBY vs. PEN, STVN, IRTC, GKOS, BLCO, TMDX, SLNO, NVST, LIVN, and INSP

Should you be buying Warby Parker stock or one of its competitors? The main competitors of Warby Parker include Penumbra (PEN), Stevanato Group (STVN), iRhythm Technologies (IRTC), Glaukos (GKOS), Bausch + Lomb (BLCO), TransMedics Group (TMDX), Soleno Therapeutics (SLNO), Envista (NVST), LivaNova (LIVN), and Inspire Medical Systems (INSP). These companies are all part of the "medical equipment" industry.

Warby Parker vs. Its Competitors

Warby Parker (NYSE:WRBY) and Penumbra (NYSE:PEN) are both medical equipment companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, profitability, earnings, dividends, media sentiment, valuation, risk and analyst recommendations.

Warby Parker has a beta of 2.09, suggesting that its stock price is 109% more volatile than the S&P 500. Comparatively, Penumbra has a beta of 0.4, suggesting that its stock price is 60% less volatile than the S&P 500.

Warby Parker presently has a consensus target price of $24.06, indicating a potential downside of 10.94%. Penumbra has a consensus target price of $300.47, indicating a potential upside of 13.52%. Given Penumbra's stronger consensus rating and higher possible upside, analysts plainly believe Penumbra is more favorable than Warby Parker.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Warby Parker
0 Sell rating(s)
8 Hold rating(s)
11 Buy rating(s)
0 Strong Buy rating(s)
2.58
Penumbra
0 Sell rating(s)
3 Hold rating(s)
13 Buy rating(s)
2 Strong Buy rating(s)
2.94

93.2% of Warby Parker shares are owned by institutional investors. Comparatively, 88.9% of Penumbra shares are owned by institutional investors. 18.2% of Warby Parker shares are owned by company insiders. Comparatively, 4.2% of Penumbra shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

In the previous week, Penumbra had 7 more articles in the media than Warby Parker. MarketBeat recorded 16 mentions for Penumbra and 9 mentions for Warby Parker. Warby Parker's average media sentiment score of 1.59 beat Penumbra's score of 1.24 indicating that Warby Parker is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Warby Parker
9 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
Penumbra
12 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Penumbra has a net margin of 11.54% compared to Warby Parker's net margin of -1.12%. Penumbra's return on equity of 11.55% beat Warby Parker's return on equity.

Company Net Margins Return on Equity Return on Assets
Warby Parker-1.12% -0.79% -0.41%
Penumbra 11.54%11.55%8.76%

Penumbra has higher revenue and earnings than Warby Parker. Warby Parker is trading at a lower price-to-earnings ratio than Penumbra, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Warby Parker$771.32M3.68-$20.39M-$0.07-385.97
Penumbra$1.19B8.64$14.01M$3.7670.39

Summary

Penumbra beats Warby Parker on 13 of the 17 factors compared between the two stocks.

Get Warby Parker News Delivered to You Automatically

Sign up to receive the latest news and ratings for WRBY and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding WRBY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

WRBY vs. The Competition

MetricWarby ParkerCONS PD IndustryStaples SectorNYSE Exchange
Market Cap$2.84B$33.74B$16.61B$21.32B
Dividend YieldN/A2.53%3.03%3.51%
P/E Ratio-385.9240.0318.7229.14
Price / Sales3.682.0747.4555.18
Price / Cash79.5916.6315.0924.09
Price / Book7.857.515.825.47
Net Income-$20.39M$1.23B$687.69M$992.74M
7 Day Performance-0.81%0.84%0.67%2.68%
1 Month Performance10.80%4.34%-2.32%1.53%
1 Year Performance74.20%25.25%5.27%10.77%

Warby Parker Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
WRBY
Warby Parker
2.2746 of 5 stars
$27.02
+3.6%
$24.06
-10.9%
+94.9%$2.84B$771.32M-385.923,780Positive News
Analyst Upgrade
PEN
Penumbra
4.8117 of 5 stars
$255.35
+0.9%
$300.47
+17.7%
+33.9%$9.87B$1.19B67.914,500Positive News
Insider Trade
STVN
Stevanato Group
1.7929 of 5 stars
€22.50
-0.5%
N/A+20.9%€6.81B€1.19B41.675,521Positive News
IRTC
iRhythm Technologies
1.3222 of 5 stars
$157.93
-1.7%
$157.30
-0.4%
+142.2%$5.16B$591.84M-53.902,000News Coverage
Analyst Forecast
Insider Trade
GKOS
Glaukos
4.7266 of 5 stars
$89.47
-0.4%
$127.42
+42.4%
-27.6%$5.15B$383.48M-54.22780Analyst Revision
BLCO
Bausch + Lomb
1.6965 of 5 stars
$14.49
-0.4%
$15.56
+7.4%
-6.7%$5.15B$4.79B-18.5713,500Positive News
TMDX
TransMedics Group
2.8326 of 5 stars
$125.65
-1.5%
$123.00
-2.1%
-30.9%$4.35B$441.54M65.10210News Coverage
Positive News
SLNO
Soleno Therapeutics
4.5796 of 5 stars
$68.09
-4.9%
$114.30
+67.9%
+41.1%$3.81BN/A-16.4530News Coverage
Analyst Forecast
Analyst Revision
NVST
Envista
3.8453 of 5 stars
$20.75
+0.5%
$20.92
+0.9%
+20.6%$3.43B$2.51B64.8312,300Positive News
LIVN
LivaNova
2.4459 of 5 stars
$53.27
-0.8%
$59.29
+11.3%
+21.4%$2.93B$1.25B-13.692,900News Coverage
Analyst Forecast
INSP
Inspire Medical Systems
4.9383 of 5 stars
$88.28
+0.6%
$165.62
+87.6%
-48.6%$2.60B$802.80M51.031,246News Coverage
Positive News
Short Interest ↓

Related Companies and Tools


This page (NYSE:WRBY) was last updated on 8/23/2025 by MarketBeat.com Staff
From Our Partners